Aeterna Zentaris to Announce Third Quarter 2012 Financial and Operating Results on November 13, 2012

   Aeterna Zentaris to Announce Third Quarter 2012 Financial and Operating
                         Results on November 13, 2012

PR Newswire

QUEBEC CITY, Nov. 7, 2012

QUEBEC CITY, Nov. 7, 2012 /PRNewswire/ - Aeterna Zentaris Inc. (NASDAQ: AEZS)
(TSX:AEZ) (the "Company") will announce its third quarter 2012 financial and
operating results on Tuesday, November 13, 2012, after market close. The
Company will host a conference call the next morning, Wednesday, November 14,
2012 at 8:30 a.m. (Eastern Time), to discuss these results.

Participants may access the live webcast via the Company's website at
www.aezsinc.com in the "Newsroom" section, or by telephone using the following
numbers: in Canada, 514-807-9895 or 647-427-7450, outside Canada,
888-231-8191. A replay of the webcast will also be available on the Company's
website for a period of 30 days.

About Aeterna Zentaris

Aeterna Zentaris is an oncology and endocrinology drug development company
currently investigating treatments for various unmet medical needs. The
Company's pipeline encompasses compounds at all stages of development, from
drug discovery through to marketed products. For more information, please
visit www.aezsinc.com.

SOURCE AETERNA ZENTARIS INC.

Contact:

Investor Relations
Ginette Beaudet Vallières
Investor Relations Coordinator
(418) 652-8525 ext. 265
gvallieres@aezsinc.com

Media Relations
Paul Burroughs
Director of Communications
(418) 652-8525 ext. 406
pburroughs@aezsinc.com